March 09, 2022
Vicore strengthens rare lung disease pipeline with PAH indication
Media
March 09, 2022
Nordic Nanovector Announces Presentation of Preclinical Data on Alpha37, at the American Association for Cancer Research 2022 Annual Meeting
March 09, 2022
Targovax ASA: Poster presentation at the AACR Annual Meeting
March 07, 2022
Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™
March 04, 2022
Xeris Biopharma to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
March 04, 2022
Vicore to host R&D Day
March 03, 2022
Priothera – FDA and EMA Grant Orphan Drug Designation to mocravimod for the treatment of Acute Myeloid Leukemia (AML) in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT)
March 01, 2022
Nordic Nanovector ASA: Results for the Fourth Quarter and Full Year 2021
February 28, 2022
Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer
February 28, 2022
Delays within FDA postpones CERAMENT G De Novo decision
